Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Munich, DE · Author affiliation
From the Departments of Neurology (A.B., M.E., Y.S., F.G., T.K.), Nuclear Medicine (W.K., K.T.), and Pharmacology (M.M.), Klinikum Grosshadern, University of Munich, Germany; Max-Planck Institute for Psychiatry (B.M.-M.), Munich, Germany; and Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany (T.G.)Location evidence
A plain-language reading has not been prepared for this paper yet.